Guadalupe Chavez, in Perry, IA - Licensed Practical Nurse

Guadalupe Chavez, is a Licensed Practical Nurse based in Perry, Iowa. Guadalupe Chavez is licensed to practice in Iowa (license number P45046) and her current practice location is 610 10th St, Perry, Iowa. She can be reached at her office (for appointments etc.) via phone at (515) 465-7684.

NPI number for Guadalupe Chavez is 1619448321 and her current mailing address is 610 10th St, Perry, Iowa. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1619448321.

Contact Information

	Guadalupe Chavez,
	610 10th St, Perry, IA 50220-2249
	(515) 465-7684
	(515) 465-7576

Provider's Profile

Full Name	Guadalupe Chavez
Gender	Female
Speciality	Licensed Practical Nurse
Location	610 10th St, Perry, Iowa
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1619448321
Provider Enumeration Date: 12/07/2018
Last Update Date: 12/07/2018

Medical Identifiers

Medical identifiers for Guadalupe Chavez such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1619448321	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	P45046 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Guadalupe Chavez is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Guadalupe Chavez, 610 10th St, Perry, IA 50220-2249 Ph: (515) 465-7684	Guadalupe Chavez, 610 10th St, Perry, IA 50220-2249 Ph: (515) 465-7684

News Archive

FDA approves Acton's AEROSPAN sNDA to treat asthma

Acton Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the sNDA (Supplemental New Drug Application) for AEROSPAN (flunisolide HFA, 80 mcg) Inhalation Aerosol, a hydrofluoroalkane (HFA) orally inhaled corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients 6 years of age and older.

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Following a May 15, 2014, meeting with the U.S. Food and Drug Administration (FDA), Shire plc, the global specialty biopharmaceutical company, announces today that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as we complete remaining chemistry and manufacturing work.

ARMC selects HMS to provide hospital information system applications for its general acute hospital

Arizona Regional Medical Center (ARMC) has selected Healthcare Management Systems, Inc.® (HMS) to provide hospital information system applications for its general acute hospital, located in Mesa, Ariz.

Nile completes dosing in Part B of cenderitide Phase I study for ADHF

Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that it has completed dosing the first patient in Part B of the ongoing Phase I study.

Self-control in childhood may help set people up for healthy midlife aging

Self-control, the ability to contain one's own thoughts, feelings and behaviors, and to work toward goals with a plan, is one of the personality traits that makes a child ready for school. And, it turns out, ready for life as well.

Guadalupe Chavez, - Licensed Practical Nurse in Perry, IA